Are Lab-Grown Diamonds Worth Anything?

The question of whether a lab-grown diamond is worth anything blurs two different ideas. The first is whether a lab-grown stone is a real diamond at all, which has a clean and short answer: yes, it is. The Federal Trade Commission updated its Jewelry Guides in 2018 to confirm that the word 'diamond' covers both mined and laboratory-grown stones, because they are chemically, optically, and physically identical materials⁶. A retailer who labels a stone a 'lab-grown diamond' is making a true statement under US trade rules. The full FTC text and required disclosure language is covered in Chapter 6.

The second idea, the one that drives the search query, is about resale value. Here the answer is more uncomfortable: a lab-grown diamond resold months or years after purchase typically recovers only a small fraction of the paid retail price, and the fraction has been falling. This is not unique to lab-grown stones, but the lab-grown gap is wider than the natural-diamond gap, and the reasons are structural rather than cyclical.

The right way to read 'are lab-grown diamonds worth anything' is therefore as a question about the retail-to-resale gap, and the honest answer involves three numbers: what a lab-grown stone costs new at retail, what the same stone fetches in the secondary market, and how those two numbers have been moving over time.

A 2026 lab-grown diamond at mainstream retail clears the cash register at a substantial sum. A one-carat round brilliant lab-grown stone in the most-shopped quality tier (roughly G colour, VS1 clarity, Excellent cut, IGI-graded) sits in the high hundreds of dollars to low thousands of dollars at most US retailers. A two-carat equivalent sits in the low- to mid-thousands. A three-carat equivalent sits in the mid-thousands to high single-digit thousands. These are not negligible purchases; they are large discretionary spends for most households.

The Bain Global Diamond Industry Report places polished lab-grown retail at approximately thirty per cent of natural retail in the 2023-2024 reporting window¹. That ratio reflects the wholesale price gap of roughly fourteen per cent partially being offset by retailer markups absorbing wholesale compression. The point is that 'lab-grown is cheaper' does not mean lab-grown is cheap. A buyer paying retail for a lab-grown stone is still making a meaningful financial decision.

On this site we deliberately do not publish specific retailer prices for either category, because retailer pricing is promotional, varies widely between vendors, and is not directly comparable across sources. Wholesale and market-level data from Bain, AWDC, and Paul Zimnisky provides a more stable basis for understanding the price gap. The wholesale and structural-cost analysis is in Chapter 7.

The lab-grown secondary market in 2026 is thinner than the natural-diamond secondary market and the recovery percentages are correspondingly lower. JCK and National Jeweler trade-press reporting on lab-grown buybacks observes recovery rates in the ten to thirty per cent of paid retail range for stones offered to professional buyback channels³⁴. Pawnshops and informal resale outlets often offer less, and some decline to accept lab-grown stones at all because new-production prices are falling fast enough that the secondary-market value at any given moment is uncertain.

The structural reason is straightforward. A professional buyback house prices stones at a discount to current replacement cost, because the house's exit market is to resell into the same channels that compete with new-production stones. If new lab-grown stones at the same grade are priced fifteen per cent lower today than they were two years ago, a stone purchased two years ago is worth fifteen per cent less in nominal replacement-cost terms before any buyback discount is applied. The compounding of falling replacement cost and a buyback discount produces the ten-to-thirty per cent recovery band.

A second factor is buybacks offered by the originating retailer. Some lab-grown specialists offer 'upgrade' or 'trade-up' programmes that credit a percentage of the original purchase against a larger or higher-quality replacement stone. These can effectively raise the recovery rate for a buyer who is willing to commit to a further purchase, but the credit is typically not redeemable for cash. The mechanism rewards retention within the retailer's ecosystem, not actual liquidation.

The retail-to-resale gap for lab-grown stones has been widening since 2018, not closing. The reasons are explained in Chapter 8 in detail; the shorter version is that lab-grown wholesale prices have fallen by roughly ninety per cent since 2018 while retail prices have fallen by a much smaller amount, because retailer markups have absorbed most of the wholesale compression. The buyer pays a price close to what buyers paid two or four years ago, while the resale market values the stone close to what new equivalents sell wholesale for today.

The De Beers Lightbox closure in 2025 illustrated the dynamic clearly. Lightbox launched in 2018 with lab-grown stones priced at eight hundred dollars per carat at retail, cut prices to five hundred dollars per carat in 2024, and closed entirely in 2025 after the price floor became unsustainable against third-party prices that had fallen further². Lightbox was a deliberate price-floor experiment by the natural-diamond incumbent rather than a typical independent producer, and its closure said more about the strategic limits of using lab-grown to anchor natural pricing than about lab-grown demand. Independent producers continue to sell to retail in volume, but the closure was a clean public marker that the price compression continues.

Paul Zimnisky's lab-grown wholesale price index, the most widely cited independent benchmark for lab-grown wholesale pricing, has continued to show downward pressure through 2025 and into early 2026⁵. There is no current evidence that the wholesale floor has been reached, and producers are still adding reactor capacity. The widening of the retail-to-resale gap is therefore likely to continue rather than reverse in the short term.

Natural diamond resale is not generous either, but it is meaningfully better. Trade-press reporting places typical natural diamond recovery in the twenty to fifty per cent of paid retail range, with the high end of the range applying to high-grade GIA-certified round brilliants in popular sizes (one carat, one-and-a-quarter carat, one-and-a-half carat) and the low end applying to less popular shapes and lower grades⁷. Natural diamond wholesale pricing has been more stable than lab-grown wholesale pricing, though not stable in absolute terms, and the supply structure is fundamentally different (see Chapter 9).

The honest comparison is therefore not 'natural is an investment, lab-grown is not.' Neither is an investment in any financial sense, and trade press routinely cautions against the investment framing for jewellery diamonds of any category. The honest comparison is that natural diamond resale recovers a higher fraction of paid retail than lab-grown resale, and the gap appears likely to persist.

For a buyer choosing between the two for an engagement ring or anniversary piece, the resale question is one variable among several. A buyer for whom resale value matters substantially will lean toward natural. A buyer who values the size and quality that the lab-grown discount enables and who treats the purchase as a one-way consumer purchase will lean toward lab-grown. The decision frame for engagement rings specifically is covered in this guide.

The most useful re-framing of the question is this: a lab-grown diamond is worth what someone will pay for it today. That price is the resale market price, which is ten to thirty per cent of the original retail price for most stones, and zero for some channels that decline lab-grown entirely. The stone is not worth nothing, and the difference between its purchase price and its resale price is the cost of having owned a diamond.

Read this way, the question stops being whether to buy a lab-grown stone at all and becomes whether the consumption value (the years of wearing it, the symbolism of the engagement, the visual impression of the size) is worth the purchase-to-resale gap. For many buyers, the answer is yes; for others, the answer is to buy a smaller natural stone instead. There is no universal right answer because the trade-off is personal.

The error to avoid is the one where a buyer expects the resale market to behave like a savings account. It does not, for either category, and the wider gap for lab-grown means the error is more expensive in that category. Trade publications have repeated this caution for years and the data continues to support it.

Cross-references

For the full resale analysis covering both categories, see Chapter 14. For the wholesale price history that drives the resale gap, see Chapter 8. For the production economics that explain why lab-grown wholesale keeps falling, see Chapter 7. For the certification choices that affect resale liquidity, see the Certifications reference.